This title appears in the Scientific Report :
2013
Please use the identifier:
http://dx.doi.org/10.1007/s00259-012-2251-4 in citations.
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI
Saved in:
Personal Name(s): | Galldiks, Norbert (Corresponding author) |
---|---|
Rapp, Marion / Stoffels, Gabriele / Fink, Gereon R. / Shah, N. J. / Coenen, Heinrich Hubert / Sabel, Michael / Langen, Karl-Josef | |
Contributing Institute: |
Kognitive Neurowissenschaften; INM-3 Physik der Medizinischen Bildgebung; INM-4 Nuklearchemie; INM-5 |
Published in: | European journal of nuclear medicine and molecular imaging, 40 (2013) 1, S. 22 - 33 |
Imprint: |
Heidelberg [u.a.]
Springer-Verl.
2013
|
DOI: |
10.1007/s00259-012-2251-4 |
Document Type: |
Journal Article |
Research Program: |
Imaging the Living Brain |
Publikationsportal JuSER |
Description not available. |